Abstract
IntroductionUstekinumab (UST) dose escalation has shown to be beneficial in Inflammatory bowel disease patients who had inadequate response and loss of response after initial induction and maintenance treatment. However, most...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have